MHTX OTC
Manhattan Scientifics, Inc.
1W: +0.0%
1M: -90.0%
3M: -50.0%
YTD: -90.0%
1Y: -90.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$190K
+45.6% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$190K
+45.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$108K
-89.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | $4M | -$4M | -$3M | -$1M |
| Depreciation & Amort. | $2K | $2K | $2K | $3K | $1K |
| Stock-Based Comp. | $367K | $24K | $0 | $0 | $0 |
| Change in Working Capital | $340K | $260K | $168K | $328K | $512K |
| Other Non-Cash Items | $564K | -$5M | $3M | $2M | $462K |
| Operating Cash Flow | -$316K | -$388K | -$421K | -$349K | -$190K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$4K | $0 | $0 | $0 |
| Acquisitions (Net) | $300K | $300K | $300K | $300K | $0 |
| Investment Purchases | $0 | -$300K | $0 | $0 | $0 |
| Investment Sales | $40K | $184K | $0 | $32K | $102K |
| Other Investing | $0 | $300K | $0 | $0 | $0 |
| Investing Cash Flow | $340K | $480K | $300K | $332K | $102K |
| — Financing Activities — | |||||
| Net Debt Issuance | $150K | $0 | $0 | -$40K | -$20K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $24K | $0 | $0 | $0 |
| Financing Cash Flow | $150K | $24K | $0 | -$40K | -$20K |
| Net Change in Cash | $174K | $92K | -$121K | -$57K | -$108K |
| Cash End of Period | $261K | $353K | $232K | $175K | $67K |
| Free Cash Flow | -$316K | -$392K | -$421K | -$349K | -$190K |